Abstract. Fibrillar amyloid beta (A␤) peptides are major constituents of senile plaques in Alzheimer disease (AD) brain and cause neuronal apoptosis in vitro. Bax and caspase-3 have been implicated in the pathogenesis of AD and are components of a well-defined molecular pathway of neuronal apoptosis. To determine whether A␤-induced neuronal apoptosis involves bax and/or caspase-3 activation, we examined the effect of A␤ on wild-type, bax-deficient, and caspase-3-deficient telencephalic neurons in vitro. In wild-type cultures, A␤ produced time-and concentration-dependent caspase-3 activation, apoptotic nuclear changes, and neuronal death. These neurotoxic effects of A␤ were not observed in bax-deficient cultures. Caspase-3 deficiency, or pharmacological inhibition of caspase activity, prevented caspase-3 activation and blocked the appearance of apoptotic nuclear features but not A␤-induced neuronal death. Neither calpain inhibition nor microtubule stabilization with Taxol protected telencephalic neurons from A␤-induced caspase activation or apoptosis. These results have potential implications regarding the underlying pathophysiology of AD and towards AD treatment strategies.
INTRODUCTION
The pervasive loss of mental functioning that is characteristic of Alzheimer disease (AD) is matched by an equally pervasive loss of neurons in the end-stage AD brain. The precise mechanism responsible for the pathological loss of neurons in AD is unknown, but multiple lines of evidence suggest that formation and deposition of amyloid beta (A␤) fibrils may be a primary etiologic event (1) . Fibrillar A␤ peptides, 40 to 42 amino acids in length, are the primary constituents of senile plaques, an extracellular hallmark of AD. Increased formation and deposition of fibrillar A␤ peptides has been associated with genetic mutations in amyloid precursor protein (2) , presenilin 1 (3), and presenilin 2 (4) that cause early onset AD. Fibrillar A␤ peptides are neurotoxic in vitro, capable of inducing oxidative stress (5) and apoptotic neuronal death (6) (7) (8) . Furthermore, in vivo injection of fibrillar A␤ peptides results in neuronal death, increased terminal deoxytransferase-mediated dUTP nick end labeling (TU-NEL), and behavioral deficits (9, 10) .
Although fibrillar A␤ peptides can cause apoptosis in vitro, the role of apoptosis in AD remains controversial. Apoptosis reflects the activation of a phylogenetically conserved proteolytic cascade involving the Bcl-2 and caspase protein families and terminates in a morphologically distinct cell death (i.e. cellular shrinkage, membrane blebbing, chromatin condensation, and nuclear fragmentation) (11) . Protein and mRNA expression levels of several Bcl-2 and caspase family members have been shown to be altered in the AD brain (12) (13) (14) (15) , but the morphologic characteristics of apoptosis have not been clearly demonstrated (16) . TUNEL staining of DNA double strand breaks, which is generally regarded as evidence of apoptosis, has been inconsistently found in the AD brain (17, 18) and is not regarded as specific for apoptosis (19) . Thus, the significance of apoptosis to the neuron loss in AD remains unclear.
A common apoptotic pathway that occurs in neurons involves recruitment of the proapoptotic Bcl-2 family member, bax. Upon receipt of a death signal, bax translocates to the mitochondria where it is thought to interact with antiapoptotic Bcl-2 family members to control the progression of apoptosis (20, 21) . If bax predominates, cytochrome c is released into the cytosol, where it can form a complex (apoptosome) with APAF-1 and caspase-9 (22) . In the presence of ATP or dATP, the apoptosome activates caspase-9, which then cleaves and activates the terminal effector caspase-3 (23, 24) . Caspase-3 acts on multiple death substrates to culminate in the classic morphologic features of apoptosis (25, 26) .
It has previously been demonstrated in vitro that blocking the postmitochondrial events in this pathway, i.e. caspase activation, will prevent the morphologic features of apoptosis but may or may not prevent cell death (27, 28) . Those cells that remain alive in the presence of caspase inhibitors are weakened due to the mitochondrial damage that has already occurred, including loss of mitochondrial membrane potential and release of reactive oxygen species (27, 29, 30) . We hypothesize that a similar process may occur in AD. That is, under the chronic stimulation of an apoptotic signal such as A␤, antiapoptotic mechanisms that prevent caspase activation may be upregulated, but these defenses are unable to prevent the chronic mitochondrial damage that will ultimately lead to neuronal death. Therefore, dying cells in the AD brain will not exhibit morphologic features of apoptosis despite the recruitment and activation of apoptotic molecules. In this paper, we examine whether bax and/or caspases are involved in A␤-induced neuronal apoptosis and at what point in the cell death cascade neurons are committed to die.
MATERIALS AND METHODS

Materials
A␤ and A␤(40-1) (Bachem) were prepared as 1 mM stocks in double deionized water with 0.01% acetic acid. Prior to treatment, peptides were preincubated in a 37ЊC waterbath for 3 to 5 days to promote aggregation and then diluted in media to the final desired concentration. Boc-Asp-FMK (BAF; Enzyme Systems Products) was prepared as a 100 mM stock solution in DMSO and diluted to a final concentration of 100 M with media. Taxol (Sigma), Leupeptin (Calbiochem), and Calpain Inhibitor I (Calbiochem) were prepared as 10 mM stocks in DMSO and diluted with media to final concentrations of 1 nm, 10 M, and 1 M, respectively. All materials were stored at Ϫ20ЊC as stock solutions until used.
Animals
Generation of bax-and caspase-3-deficient mice by homologous recombination in embryonic stem cells has been described (31, 32) . Heterozygous (bcl-x ϩ/Ϫ or caspase-3 ϩ/Ϫ ) male and female mice were bred to generate wild-type, heterozygous, and homozygous-deficient embryos. Endogenous and disrupted genes were detected by PCR analysis of tail DNA extracts as previously described (31, 32) .
Primary Neuronal Culture
Primary mouse telencephalic neuronal cultures were established from embryonic day 12 to 14 mice. Telencephalic vesicles were isolated in Hank's buffered saline solution (HBSS, GibcoBRL) supplemented with 15 mM HEPES, 2.7 mM sodium bicarbonate, and 33 mM glucose. Once freed from the meninges, vesicles were dissociated by digestion in trypsin/EDTA (0.1% trypsin and 0.04% EDTA with 0.001% DNAse; Sigma) at 37ЊC for 20 minutes (min). The trypsinization was stopped by addition of equal volume HBSS with 10% fetal calf serum and the tissue was then mildly triturated with a fire polished 5 ml Pasteur pipette. Dissociated cells were washed twice by centrifugation at 1,700 rpm and resuspended in Dulbecco's Modified Eagle Medium with nutrient mixture F12 (DMEM, GibcoBRL). Twenty thousand cells from each embryo were plated per well of a 48 well tissue culture plate in a chemicallydefined medium that promotes neuronal differentiation and survival as previously described (33, 34) . Prior to plating, wells were precoated with successive overnight incubations in 0.1 mg/ml poly-L-lysine (Sigma) and 0.01 mg/ml laminin (Collaborative Biomedical Products). Cultures were maintained in a humidified incubator with 5% CO 2 at 37ЊC.
Immunocytochemistry
Fixed cells were incubated for 30 min in PBS-blocking buffer containing bovine serum albumin and powdered nonfat milk followed by overnight incubation at 4ЊC with mouse anti-microtubule-associated protein 2 antibodies (MAP2; 1:1million; Sigma) or with a rabbit polyclonal antiserum that detects activated caspase-3 (CM1; 1:1:100,000) as previously described (35) . Immunostaining was detected using a modified tyramide signal amplification (TSA, NEN Life Sciences) protocol. No immunoreactivity was observed if primary antibodies were coapplied with excess antigen or if primary antibodies were omitted (data not shown).
Nuclear Staining, and Dye Exclusion Assays
Cell nuclei were labeled with a 0.25 g/ml solution of bisbenzimide (Hoechst dye 33258; Sigma) for 10 min at room temperature. Apoptotic nuclear morphology was determined by abnormal condensation and/or fragmentation of nuclei. As an objective measure of cell death, vital dye exclusion was used. Prior to fixation, propidium iodide (PI, 0.5 g/mL; Molecular Probes) or SYTOX Green (500 nm; Molecular Probes) was added directly to wells for 30 min. PI labeled wells were then fixed with Bouin's fixative and SYTOX Green-labeled wells were fixed in a 4% paraformaldehyde solution. ) for comparisons with the knock-out conditions. Statistical significance was determined by the nonparametric Wilcoxin rank sign test followed by Dunn's post-hoc test to compare treatment groups of unequal sizes; differences were considered significant when p Ͻ 0.05.
Statistical Analysis
RESULTS
Concentration and Time Dependence of A␤-induced Apoptosis
A␤ has been shown to induce apoptosis in primary neuronal cultures (6, 8) . However, the neurotoxic effect of A␤ is concentration-and time-dependent (36), as well as cell type-dependent (37) . In order to establish that A␤ is capable of inducing apoptosis in our neuronal cell culture system, we assessed the nuclear phenotype of our primary cell cultures after 24 hours (h) exposure to increasing concentrations of A␤ (Fig. 1a) . Additionally, we looked for evidence of caspase-3 activation (Fig. 1c) since this protein is causally linked to apoptosis in the developing nervous system. We have previously demonstrated that apoptotic nuclear morphology closely correlates with TUNEL staining and caspase-3 activation in this experimental system (35) . . Concentration-and time-dependent A␤-induced apoptosis. Primary neuronal cultures exposed to A␤(1-40) for 24 h exhibited increased apoptotic nuclear morphology (A) and CM1 immunoreactivity (C) with increased concentrations of the A␤ peptide. Statistically significant increases in apoptotic nuclear morphology and CM1 immunoreactivity were achieved with concentrations of 20 g/ml and greater (Data shown from 1 experiment, n ϭ 4, p Ͻ 0.05). Addition of A␤ at a concentration of 40 g/ml also resulted in increased apoptotic nuclear morphology (B) and CM1 immunoreactivity (D) as the length of exposure to the peptide was increased (circles ϭ control; squares ϭ A␤-exposed). Compared with media alone, statistically significant increases in apoptotic nuclear morphology and CM1 immunoreactivity were achieved within 24 h (n ϭ 8; p Ͻ 0.05). Addition of the reverse A␤ peptide, A␤ , to primary neuronal cultures was not statistically different from media alone at any concentration or time point tested (data not shown).
Addition of 10 g/ml of A␤ did not cause a significant increase in either immunocytochemical detection of activated caspase-3 or in the percentage of condensed or fragmented (apoptotic) nuclei. Starting at a concentration of 20 g/ml, A␤ caused a significant increase in both apoptotic nuclear morphology and activated caspase-3 immunodetection. A maximal effect was seen at the highest concentration tested of 160 g/ml. We chose a concentration of 40 g/ml, which was roughly, the ED 50 , and assessed A␤-induced apoptosis over time (Fig. 1b, d) . Within 24 h, there was a significant increase in cells displaying an apoptotic nuclear morphology and activated caspase-3 immunoreactivity. Within 72 h, nearly all cells had apoptotic nuclei although the number of cells with caspase-3 activity had leveled off at about 50%. This most likely reflects the fact that dead cells are not cleared by phagocytosis in our low density cultures, thus allowing neuronal corpses to remain for long periods of time.
These metabolically inactive cells will lose most of their protein content over time, including caspase-3. At earlier time points, there is a virtual one-for-one association between apoptotic nuclear morphology, activated caspase-3 immunodetection, and neuronal death. A␤ also induced a concentration-and time-dependent loss of MAP2 immunoreactivity with only rare cells exhibiting both CM1 and MAP2 immunoreactivities (data not shown).
A␤ Kills Caspase-3-deficient Neurons
Caspase-3 is a downstream effector molecule that is required for the nuclear changes associated with apoptosis in the nervous system (25, 26) . Preventing the activity of caspase-3 may rescue cells from death (28, 38) , or may not (30, 39) . To characterize the significance of caspase type cultures, did not have a significant increase in the percentage of neurons with nuclear features of apoptosis (Fig.2a) . Indeed, there was no evidence of nuclear fragmentation and only rare cells were condensed (data not shown). As expected, caspase-3-deficient cultures, either with or without the addition of A␤, did not exhibit activated caspase-3 immunoreactivity (Fig. 2b) . Interestingly, although caspase-3-deficient neurons exposed to A␤ did not have the nuclear phenotype of apoptosis, they were not rescued from cell death when assessed by vital dye exclusion (Fig. 2c) and they still lost MAP2 immunoreactivity (data not shown).
Bax Deficiency Prevents A␤-induced Death
Caspase-3 activation can be bax-dependent or independent (27, 30, 35) . Bax is an upstream effector of apoptosis that mediates multiple events at the mitochondria. Not only does bax propagate the apoptotic signal via cytochrome c release into the cytosol, but it also causes loss of mitochondrial membrane potential and release of reactive oxygen species (39) . The inability of caspase-3 deficiency to rescue neurons from A␤-induced death may be due to the fact that it acts downstream from these cytotoxic mitochondrial events induced by bax. Bax deficiency prevents these mitochondrial events from occurring, and therefore may rescue neurons from A␤-induced neurotoxicity.
Similar to caspase-3-deficient cultures, there was no evidence of nuclear fragmentation and only rare condensed nuclei in bax-deficient cultures treated with A␤ (Fig. 3a) . This corresponded to a nearly complete lack of activated caspase-3 immunodetection (Fig. 3b) . Therefore, A␤-induced caspase-3 activation and apoptosis, in this experimental system, is dependent on bax. However, unlike caspase-3-deficient neurons, bax-deficient neurons were rescued from A␤-induced death (Fig. 3c) . This suggests that A␤ commits neurons to die simultaneous with, or at some point after, bax translocation to the mitochondria and prior to activation of caspase-3. Additional experiments will be necessary to determine whether bax deficiency prevents A␤-induced neuronal death or merely delays it past the 48-h time point analyzed in these experiments.
Caspase Inhibition Does Not Prevent A␤-induced Death
Other effector caspases may cause apoptosis and baxdependent caspase-3 activation and apoptosis involves the activation of an intermediate caspase, caspase-9 (23, 24, 40) . To determine if caspases other than caspase-3 are involved in A␤-induced neuronal death, wild-type neurons were coincubated with A␤ and BAF. BAF is a broad spectrum irreversible active site inhibitor of caspases (28, 41) . In the presence of BAF, A␤ did not cause nuclear morphological features of apoptosis (Fig. 4a) or activation of caspase-3 (Fig. 4b) . Similar to caspase-3 deficiency, however, BAF was unable to prevent A␤-induced death (Fig. 4c) or loss of MAP2 immunoreactivity (data not shown), despite the fact that it blocked the development of apoptotic morphology. This places the death commitment point upstream of caspase-9 activation and suggests that other caspase effectors (e.g. caspase-6 and -7) are not involved in A␤-induced death.
A␤-induced Apoptosis Is Not Mediated Through Microtubule Destabilization
It is unknown how A␤ activates the apoptotic cascade and causes translocation of bax to the mitochondria. We have observed that A␤ causes a rapid loss in MAP2 immunoreactivity that precedes, or occurs simultaneous with, apoptotic nuclear morphologic changes and death. MAP2 is the primary microtubule-associated protein in dendritic processes of neurons and is required for maintenance of microtubule integrity (42) . Microtubule destabilizers have previously been shown to induce caspase-3-dependent apoptosis mediated through cytochrome c release from the mitochondria (43) . In light of this, we hypothesized that A␤-induced microtubule damage may be an upstream event in the activation of apoptosis. However, addition of microtubule stabilizing concentrations of Taxol had no effect on A␤-induced nuclear apoptotic morphology, caspase-3 activation, or death (Fig. 5 and data not shown).
Calpains Clear MAP2 from Apoptotic Neurons
It is also known that A␤ can increase intracellular calcium levels and calcium channel blockers can attenuate A␤-induced neurotoxicity (44) . Calcium activated neutral proteases (calpains) are increased in AD (45) and are immunolabeled in senile plaques (46, 47) . In addition, calpains are the primary proteases responsible for catabolism of MAP2 (48) and have been implicated in apoptosis (49, 50) . We therefore hypothesized that calpain activation may be an early event in A␤-induced apoptosis. However, neither addition of Leupeptin or Calpain Inhibitor I affected A␤-induced nuclear apoptotic morphology (Fig. 6a, d ) or caspase-3 activation (Fig. 6b, e) . Interestingly, both inhibitors produced a retention of MAP2 immunoreactivity in apoptotic neurons (Fig. 6c, f) . Our data suggest that calpains are involved in the degradation phase of apoptosis, after the cells are committed to die, and are responsible for the clearance of MAP2 from dying neurons.
DISCUSSION
In the studies reported here, we have demonstrated that A␤ can activate an apoptotic pathway involving bax and caspase-3. Interestingly, caspase-3 activation, although required for the morphologic features of apoptosis, is not required for A␤-induced neuronal death. Bax, on the other hand, acts upstream in the cell death pathway and is required for A␤-induced neuronal death. These observations suggest that the mitochondrial changes induced by bax determine whether a neuron lives or dies in response to A␤ and that caspase-3 activation determines its phenotypic appearance.
These results are consistent with previous in vitro findings. A␤ upregulates expression of bax and alters the expression of the antiapoptotic proteins, Bcl-2 and Bcl-X L (51, 52) . Furthermore, increased expression of Bcl-2 (53, 54) and Bcl-X L (55) have been shown to inhibit A␤-induced neurotoxicity. It is proposed that these antiapoptotic proteins interact with bax and function as a rheostat for propagation of apoptotic signals (39) . If bax predominates, the signal is transmitted via release of cytochrome c into the cytosol and activation of downstream caspases. The recruitment of type 2 caspases, which include caspase-3, has been implicated by the observation of increased fluorogenic substrate cleavage following exposure to A␤ peptides (56, 57) . In some systems, caspase inhibition prevents apoptosis, but the cells still die, presumably due to mitochondrial damage (39); alternatively, they may become more susceptible to other toxic insults . Neither BAF nor Taxol inhibit A␤-induced neurotoxicity. Primary telencephalic cultures exposed to 40 g/ml of A␤ for 48 h in the presence of 100 M BAF exhibited few fragmented or condensed apoptotic nuclei (A) and rare CM1 immunoreactive cells (B). However, nuclei appeared smaller and most cells were dead when assessed by vital dye exclusion with SYTOX Green (C). Addition of 1 nm Taxol had no effect on A␤-induced apoptotic nuclear morphology (D), CM1 immunoreactivity (E), or SYTOX Green staining (F). All conditions were tested in duplicate wells and repeated in 4 independent experiments; photomicrographs are from a representative experiment. Fig. 6 . Leupeptin inhibits A␤-induced MAP2 degradation but not neurotoxicity. Cells were plated at time 0 and A␤ was added 48 h later either without (A-C) or with (D-F) 10 nm Leupeptin. After an additional 48 h, the cells were fixed and apoptotic nuclear morphology, (A, D), CM1 immunoreactivity (B, E), and MAP2 immunoreactivity (C, F) was assessed. A␤ alone resulted in neuronal death characterized by apoptotic nuclear morphology (A), increased CM1 immunoreactivity (B), and loss of MAP2 immunoreactivity (C). Although Leupeptin had no effect on A␤-induced apoptotic nuclear morphology (D) or CM1 immunoreactivity (E), MAP2 immunoreactivity was retained in dead and dying neurons (F). All conditions were tested in duplicate wells and repeated in 3 independent experiments; photomicrographs are from a representative experiment. (58) . Indeed, caspase inhibitors do not prevent the release of reactive oxygen species from the mitochondria during apoptosis (27) and antioxidants can prevent A␤-induced neuronal death (5, 53, 59) .
Based on these findings, we speculate that similar events may occur in AD. Bax mRNA (60, 61) and protein (13) levels are increased in AD and increased bax immunoreactivity has been detected in senile plaques (62) . Similarly, Bcl-2 mRNA and protein levels, as well as bclx mRNA levels, are altered in AD patients versus agematched controls (12, 13, 15 and apoptosis (63) and neuronal caspase-3 immunoreactivity has been reported to be increased in AD brain (15) . However, other investigators have found no difference in caspase-3 mRNA (14) or protein (12) expression levels between AD brain samples and age-matched controls. Furthermore, we have previously reported that cortical brain sections from AD patients do not exhibit caspase-3 activation despite numerous senile plaques and neurodegenerative changes (8) . Based on these findings, we speculate that adaptive responses are induced in the AD brain that inhibit caspase-3 activation and prevent the morphologic features of apoptosis despite the altered activity of several apoptosis-associated molecules.
This suggests that therapeutic targets for AD must interfere early in the cell death cascade at or prior to involvement of the mitochondria. Caspase inhibition (64, 65) , calpain inhibition (66) , and microtubule stabilization (56, 67 ) have all been suggested as possible therapeutic targets for AD. However, any therapeutic effects these agents might have would likely be independent of A␤-induced neurotoxicity. In our experimental system, caspase inhibitors prevent A␤-induced nuclear features of apoptosis, but have no effect on neuronal survival. Likewise, calpain inhibitors can prevent the degradation and clearance of MAP2 from dying neurons, but have no impact on the nuclear morphology or kinetics of neuronal death. Finally, although direct microtubule damage can lead to cytochrome c release, caspase-3 activation, and apoptosis (43) , addition of Taxol at concentrations that are known to promote microtubule polymerization had no effect on A␤-induced neurotoxicity.
We have previously reported activated caspase-3 immunoreactivity in hippocampal neurons undergoing granulovacuolar degeneration (8) . Others have similarly reported caspase-3 activation in AD hippocampal pyramidal neurons (68) , and caspase inhibitors can protect hippocampal neurons from A␤-induced death in vitro (57, 59) . Furthermore, caspase-3 is capable of processing APP (68, 69) , PS1 (70) , and PS2 (71) , and has been implicated in the generation of fibrillar A␤ peptides (68) . Therefore, although our data suggests that caspase inhibitors may not be able to prevent the global loss of cortical neurons in the AD brain, they may have therapeutic potential by blocking nonapoptotic, yet potentially neurotoxic events in hippocampal neurons that function in learning and memory.
